Organixs Science

Explore the Science

Understand your body. Follow the evidence.

From the liver and cardiovascular system to metabolism, digestion and healthy aging — explore evidence-based explanations of how the human body works, and what current research is revealing.

BRAIN HEART LIVER GUT KIDNEYS
Latest Research

A closer look at what new research is revealing

Every article links to a real, citable source — no invented studies, no placeholder statistics.

MASLD / MASH Research update · 2024–2025
Human clinical trials (Phase 3)

Two new drug classes show histologic benefit in MASH

Large randomized trials now support two distinct approaches to MASH with fibrosis: a thyroid-hormone-receptor agonist and a GLP-1 receptor agonist. Both improved liver histology in controlled trials; longer-term outcome data are still accumulating.

Strong evidence Multiple large, randomized, placebo-controlled human trials with consistent histologic results. Explore →
Harrison SA et al., N Engl J Med 2024;390:497–509 · Sanyal AJ et al., N Engl J Med 2025
Blood Pressure Research update · August 2025
Clinical practice guideline

AHA/ACC replace their blood pressure guideline for the first time since 2017

Thirteen medical societies jointly updated the diagnostic threshold framework and risk calculator for high blood pressure, and gave firmer encouragement toward a systolic target below 120 mmHg for many adults.

Clinical guideline Multi-society consensus built on a structured review of trial evidence published since 2015. Explore →
2025 AHA/ACC Multisociety Guideline, J Am Coll Cardiol 2025;86(18):1567–1678
Gut Microbiome Research update · May 2025
Scientific review

What short-chain fatty acids actually do in the body

A major review consolidates how compounds made when gut bacteria ferment fiber interact with the immune system, gut barrier and metabolism — and where the mechanisms are still being worked out.

Moderate evidence Strong mechanistic and preclinical evidence; human clinical evidence is still developing for many claims. Explore →
Mukhopadhya I, Louis P., Nat Rev Microbiol 2025;23(10):635–651
Insulin Resistance Research update · January 2026
Systematic review & meta-analysis

Continuous glucose monitors mainly help people who aren't healthy yet

A fresh review of 23 studies in non-diabetic users found CGM use improved blood glucose and dietary adherence overall — but splitting by group showed the benefit concentrated in people with prediabetes, with no appreciable glycemic benefit in already-healthy users.

Moderate evidence Meta-analysis of mostly small, short-duration studies; few were long-term randomized trials. Explore →
Zhong T, et al., Eur J Med Res 2026;31:397
Science vs Hype

Health information moves fast. Evidence moves carefully.

We take popular health claims and compare them with what the evidence actually shows.

Does a fatty liver always cause symptoms?

What people hear

"Fatty liver is harmless if you feel fine."

What the evidence says

MASLD is frequently silent. Fibrosis stage — not symptoms — is the strongest predictor of long-term liver-related outcomes, which is why screening focuses on metabolic risk factors rather than how someone feels.

Severity varies widely between people with the same diagnosis. Most people with simple steatosis never progress to advanced disease, but a subset develop inflammation (MASH) and, over years, fibrosis — which is why clinical guidelines recommend risk-based screening rather than waiting for symptoms.

Does magnesium lower blood pressure?

What people hear

"Magnesium supplements lower blood pressure."

What the evidence says

A 2025 meta-analysis of 38 randomized trials found a modest average reduction — about 2.8 mmHg systolic — that was considerably larger in people with hypertension or low magnesium, and not significant in normotensive people.

Across 2,709 participants, magnesium reduced systolic BP by ~2.8 mmHg and diastolic BP by ~2.1 mmHg on average versus placebo. People already on blood-pressure medication or with confirmed low magnesium saw larger drops (up to ~7.7 mmHg systolic); people with normal blood pressure saw no statistically significant change. The authors also flagged high heterogeneity across the underlying studies — a reason to treat the average effect with some caution.
Zhang X et al., Magnesium Supplementation and Blood Pressure, Hypertension 2025

Is the gut microbiome responsible for everything?

What people hear

"Fix your gut, fix everything."

What the evidence says

Gut bacteria genuinely influence metabolism and immune signaling — that part is established. Whether shifting the microbiome reliably improves most of the conditions it's associated with is still an open, active question.

Established: gut bacteria ferment fiber into short-chain fatty acids that affect gut-barrier integrity and immune function. Plausible: microbiome differences are associated with conditions from obesity to mood, in observational research. Speculative: whether those differences are a cause, a consequence, or a bystander — and whether probiotics or diet changes reliably shift outcomes for most people.
Evidence Framework

Evidence Strength

How we describe the quality and consistency of research behind a claim — not a verdict on whether something is good or bad.

Strong
01
Moderate
02
Emerging
03
Limited
04
Preclinical
05
Multiple high-quality human studies and/or consistent clinical evidence.
"Evidence strength describes the quality and consistency of available research for a specific claim. It does not mean that an ingredient or intervention is inherently good or bad."
Why Evidence Matters

We don't expect you to take our word for it

Every article on this site separates four things, clearly and consistently:

What we know

Strongly supported by high-quality human evidence.

What the evidence suggests

Promising evidence, but limitations remain.

What is emerging

Early research requiring further investigation.

What remains uncertain

Insufficient, conflicting or evolving evidence.